164 related articles for article (PubMed ID: 16209887)
1. Enhancement of the cytotoxicity of titanocene dichloride by aging in organic co-solvent.
Ravera M; Cassino C; Monti E; Gariboldi M; Osella D
J Inorg Biochem; 2005 Dec; 99(12):2264-9. PubMed ID: 16209887
[TBL] [Abstract][Full Text] [Related]
2. Study of the cytotoxicity and particle action in human cancer cells of titanocene-functionalized materials with potential application against tumors.
García-Peñas A; Gómez-Ruiz S; Pérez-Quintanilla D; Paschke R; Sierra I; Prashar S; del Hierro I; Kaluđerović GN
J Inorg Biochem; 2012 Jan; 106(1):100-10. PubMed ID: 22112846
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic studies of substituted titanocene and ansa-titanocene anticancer drugs.
Gómez-Ruiz S; Kaluderović GN; Prashar S; Polo-Cerón D; Fajardo M; Zizak Z; Sabo TJ; Juranić ZD
J Inorg Biochem; 2008 Aug; 102(8):1558-70. PubMed ID: 18353439
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, cytotoxicity, and hydrolytic behavior of C2- and C1-symmetrical Ti(IV) complexes of tetradentate diamine bis(phenolato) ligands: a new class of antitumor agents.
Peri D; Meker S; Shavit M; Tshuva EY
Chemistry; 2009; 15(10):2403-15. PubMed ID: 19156656
[TBL] [Abstract][Full Text] [Related]
5. A new generation of anticancer drugs: mesoporous materials modified with titanocene complexes.
Pérez-Quintanilla D; Gómez-Ruiz S; Zizak Z; Sierra I; Prashar S; del Hierro I; Fajardo M; Juranić ZD; Kaluderović GN
Chemistry; 2009; 15(22):5588-97. PubMed ID: 19370742
[TBL] [Abstract][Full Text] [Related]
6. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
Waern JB; Dillon CT; Harding MM
J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
[TBL] [Abstract][Full Text] [Related]
7. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
Abeysinghe PM; Harding MM
Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034
[TBL] [Abstract][Full Text] [Related]
8. Different ortho and para electronic effects on hydrolysis and cytotoxicity of diamino bis(phenolato) "salan" Ti(IV) complexes.
Peri D; Meker S; Manna CM; Tshuva EY
Inorg Chem; 2011 Feb; 50(3):1030-8. PubMed ID: 21214265
[TBL] [Abstract][Full Text] [Related]
9. Improvement of cytotoxicity of titanocene-functionalized mesoporous materials by the increase of the titanium content.
Kaluderović GN; Pérez-Quintanilla D; Zizak Z; Juranić ZD; Gómez-Ruiz S
Dalton Trans; 2010 Mar; 39(10):2597-608. PubMed ID: 20179853
[TBL] [Abstract][Full Text] [Related]
10. Heteroaryl substituted titanocenes as potential anti-cancer drugs.
Sweeney N; Gallagher WM; Müller-Bunz H; Pampillón C; Strohfeldt K; Tacke M
J Inorg Biochem; 2006 Sep; 100(9):1479-86. PubMed ID: 16764931
[TBL] [Abstract][Full Text] [Related]
11. Osmium NAMI-A analogues: synthesis, structural and spectroscopic characterization, and antiproliferative properties.
Cebrián-Losantos B; Krokhin AA; Stepanenko IN; Eichinger R; Jakupec MA; Arion VB; Keppler BK
Inorg Chem; 2007 Jun; 46(12):5023-33. PubMed ID: 17497853
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and assessment of the cytotoxic properties of cis and trans-[Pd(L)(2)Cl(2)] complexes involving 6-benzylamino-9-isopropylpurine derivatives.
Trávnícek Z; Szucová L; Popa I
J Inorg Biochem; 2007 Mar; 101(3):477-92. PubMed ID: 17208304
[TBL] [Abstract][Full Text] [Related]
13. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW
Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
[TBL] [Abstract][Full Text] [Related]
16. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
[TBL] [Abstract][Full Text] [Related]
17. Titanium(IV) targets phosphoesters on nucleotides: implications for the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Guo Z; Sadler PJ
J Biol Inorg Chem; 2001 Sep; 6(7):698-707. PubMed ID: 11681703
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxicity studies of new dimethylamino-functionalised and aryl-substituted titanocene anti-cancer agents.
Pampillón C; Claffey J; Strohfeldt K; Tacke M
Eur J Med Chem; 2008 Jan; 43(1):122-8. PubMed ID: 17412456
[TBL] [Abstract][Full Text] [Related]
19. Dimethyl titanocene Y: a valuable precursor for libraries of cytotoxic titanocene derivatives.
Immel TA; Martin JT; Dürr CJ; Groth U; Huhn T
J Inorg Biochem; 2010 Aug; 104(8):863-7. PubMed ID: 20452674
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.
Hernández R; Lamboy J; Gao LM; Matta J; Román FR; Meléndez E
J Biol Inorg Chem; 2008 Jun; 13(5):685-92. PubMed ID: 18288505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
